{"id":"W4390350213","doi":"10.14740/gr1664","title":"Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn’s Disease and Ulcerative Colitis","year":2023,"lang":"en","type":"article","venue":"Gastroenterology Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Cochrane Library; Placebo; Crohn's disease; Inflammatory bowel disease; Meta-analysis; Adalimumab; Adverse effect; Randomized controlled trial; Gastroenterology; Disease; Pathology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01444598,0.0009395347,0.007189753,0.004070811,0.0003782464,0.002116965,0.001059031,0.002246502,0.002169992],"category_scores_gemma":[0.02823454,0.0006936986,0.01070981,0.003369926,0.0009169597,0.00150285,0.0008955405,0.001375147,0.0001292614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001246889,"about_ca_system_score_gemma":0.002201682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001374307,"about_ca_topic_score_gemma":0.003109127,"domain_scores_codex":[0.984502,0.008827298,0.00416119,0.0007529705,0.00157379,0.000182663],"domain_scores_gemma":[0.9757444,0.01741643,0.005084818,0.0003092468,0.001086885,0.0003581972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"observational","study_design_scores_codex":[0.09876993,0.0006996217,0.007154861,0.5621161,0.2518978,0.0002503764,0.0003591792,0.0005942368,0.001772774,0.0006363547,0.0006827782,0.07506589],"study_design_scores_gemma":[0.07120239,0.03743394,0.02844482,0.1103972,0.7373714,0.0006994522,0.0005208482,0.0007162872,0.001478589,0.001427311,0.01016198,0.0001457871],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02744874,0.9703678,0.0002022308,0.0003421184,0.0002535725,0.000584504,0.0001925463,0.000006153077,0.0006021764],"genre_scores_gemma":[0.4566383,0.5370021,0.002109816,0.001442987,0.0006116555,0.00133621,0.0004715194,0.00001058039,0.000376958],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01444598,"threshold_uncertainty_score":0.07639861,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03024862191776924,"score_gpt":0.3163192889374688,"score_spread":0.2860706670196996,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}